mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.002 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.004 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.005 |